Good Doctor. Hot Infusion | Reprinted: New Breakthrough in Cancer Treatment! Our Interventional Department Successfully Conducted the First Case of Intraperitoneal Hyperthermic Perfusion Treatment
2025-06-24
// Prevention and Control Tumor implantation metastasis Curbing cancerous effusion in body cavities 。
June 6, 2025, Interventional Department of our hospital Successfully conducted the first case of intraperitoneal hyperthermia perfusion treatment ,to alleviate the suffering of gastric cancer patients with ascites. The success of this treatment has added a highly efficient method to our hospital's comprehensive tumor treatment, and will rely on "Multi-cavity, minimal trauma, metastasis control, effusion treatment" advantages, to formulate scientific treatment plans for more patients and promote the improvement of tumor treatment level. This treatment uses a minimally invasive circulatory technique with acupuncture, external puncture and catheterization, under computer monitoring and adjustment, so that 42.5℃ Perfusion solution Constant temperature circulation for 60 minutes, can be combined with heat-sensitive chemotherapeutic drugs, synergistic killing of free cancer cells and micro-implantation metastasis foci. Extend life, quality of life!
Case
| Gastric malignant tumor patient -- peritoneal effusion

Patient: Xi Moumou, Male, 67 years old
Chief complaint: Gastric malignant tumor found, abdominal distension, heartburn, aggravated with fatigue for 2 weeks
Present illness: The patient developed poor appetite without obvious inducement, and sudden weight loss of 5kg. Persistent abdominal distension and heartburn. CT showed extensive lymph node metastasis in the retroperitoneum, peritoneal implantation metastasis with A large amount of peritoneal effusion Formation, admitted to the hospital with a diagnosis of "gastric malignant tumor" in the outpatient department.
// Expert team conducts body cavity hyperthermia perfusion treatment for the patient

The expert professor team of the Interventional Department of our hospital conducted a consultation for the patient and formulated a "body cavity hyperthermia perfusion treatment" plan.

Before treatment: The patient's swollen abdomen before treatment.

External puncture and catheter placement ,after automatically heating the perfusion solution in the body cavity hyperthermia perfusion treatment machine, it is injected into the body cavity. Under the dynamic detection and feedback adjustment of the computer throughout the process, Maintain the perfusion solution at a treatment temperature of 42.5℃, continuous constant temperature circulation for 60 minutes ,patient A large amount of tumor tissue was found in the body cavity effusion flushed out from the abdomen, and the color was dark brown.

Through continuous circulation flushing, the color of the patient's body cavity effusion became lighter and clearer.
Physical flushing principle: The shear force of liquid flow can directly lead to the death of tumor cells, and liquid flushing can remove free cancer cells and micro-metastasis foci.

Using the principle of chemotherapy synergy, some chemotherapeutic drugs were added for the first time.
Chemotherapy synergy principle: With Heat-sensitizing Chemotherapy drugs Substances. The sensitivity is greatly increased after heating. The efficacy increases exponentially, improving the effect of chemotherapy. The external tubing volume is less than 500ml, which is convenient for precise clinical medication. 。

Tumor thermal killing principle: The sensitivity of tumor tissue and normal human tissue to heat is different. The combined effect of 42.5℃ + 60 minutes can exponentially increase the mortality rate of cancer cells.

(The effective circulation of intraperitoneal hyperthermia perfusion can be clearly seen under B-ultrasound)
(After the treatment, comparison of the patient's abdomen before and after treatment)

(Body cavity hyperthermia perfusion machine, tumor tissue filtered in the filter)

(60 minutes of body cavity hyperthermia perfusion treatment is completed, comparison of effusion before and after treatment)

(Some chemotherapeutic drugs are added again)

(After the treatment, the patient is in good condition)
Body cavity hyperthermia perfusion treatment plan
Green, safe, new method of adjuvant tumor treatment

Clinical indications
Treatment of gastric cancer, lung cancer, colorectal cancer, intraoperative and postoperative prevention and control of implantation metastasis.
Perfusion treatment of cancer cells, metastatic nodules and residual lesions that cannot be removed by surgery.
Perfusion treatment of malignant body cavity effusion (pleural cavity, peritoneal cavity).
Perfusion treatment of ovarian cancer metastasis.
Malignant chest Peritoneal mesothelioma Treatment.
Clinical practical value
Characteristics of internal medicine use
Minimally invasive, can be used in conjunction with minimally invasive pre-placed puncture needles and drainage tubes to achieve effective circulation.
Suitable for the treatment of malignant body cavity effusion caused by thoracic and abdominal cancer and postoperative prevention of metastasis.
Can be used repeatedly multiple times according to the chemotherapy cycle.
Precise multi-channel temperature monitoring of the thoracic and abdominal cavities.
External tubing volume is less than 500ml, which is convenient for precise clinical medication.
Removable filters can be used in combination to ensure the removal of cancer cells.
Wide range of applications, convenient for multi-departmental use.
Surgical Features
It has a multi-channel temperature monitoring function with multiple inputs and outputs.
It has an intraoperative high-flow lavage function.
It has an automatic drainage function for intraoperative perfusion fluid.
Suitable for the treatment of late-stage or advanced thoracic and abdominal cancers.
External tubing volume is less than 500ml, which is convenient for precise clinical medication.
It can be used with laparoscopy to perform hyperthermic intraperitoneal chemotherapy (HIPEC).
Removable filters can be used in combination to ensure the removal of cancer cells.
Contraindications
Patients with severe thoracic and abdominal adhesions;
Bowel obstruction, hepatic cirrhosis with ascites;
ECOG > 2, extremely debilitated physical condition, unable to tolerate hyperthermic intraperitoneal chemotherapy;
Patients with bleeding tendency;
Patients with uncontrolled hypertension, heart disease, cerebrovascular accident, coronary heart disease, and arrhythmia;
Patients with late-stage malignant body cavity effusion and organ failure in one or more major organs such as the heart, lungs, liver, and kidneys;
Patients with inguinal hernia, Diaphragmatic hernia Patients;
Patients with poor compliance.
Medical Consultation
Hospital Address: No. 36, Baishazhou Avenue, Hongshan District, Wuhan City
Contact Number: 027-88082999
Key words:
Related News